BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 6258534)

  • 21. [[Studies of tumor specific antigens on leukemic cells by mixed lymphocyte-leukemic cell cultures (author's transl)]?9H].
    Ohno R; Morishima Y; Kato Y; Sugiura S; Takeyama H
    Nihon Ketsueki Gakkai Zasshi; 1977 Apr; 40(2):177-82. PubMed ID: 329627
    [No Abstract]   [Full Text] [Related]  

  • 22. Herpesvirus type 1 serum antibodies and brain tumors in humans.
    Hadfield MG; Murray BK; Thomson TA; Young HF
    Clin Neuropathol; 1984; 3(2):68-71. PubMed ID: 6325061
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A DNA vaccine expressing tyrosinase-related protein-2 induces T-cell-mediated protection against mouse glioblastoma.
    O I; Blaszczyk-Thurin M; Shen CT; Ertl HC
    Cancer Gene Ther; 2003 Sep; 10(9):678-88. PubMed ID: 12944987
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Immunological diagnostic laboratory tests (author's transl)].
    Bartmann K
    Prax Klin Pneumol; 1979 Apr; 33 Suppl 1():277-87. PubMed ID: 379846
    [No Abstract]   [Full Text] [Related]  

  • 25. Immunotreatment in patients with glioblastoma multiforme--a histopathological evaluation of reactive and inflammatory changes.
    Persson A; Skagerberg G; Salford LG; Englund E;
    Clin Neuropathol; 2005; 24(5):201-8. PubMed ID: 16167543
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vitro interleukin 12 activation of peripheral blood CD3(+)CD56(+) and CD3(+)CD56(-) gammadelta T cells from glioblastoma patients.
    Fujimiya Y; Suzuki Y; Katakura R; Miyagi T; Yamaguchi T; Yoshimoto T; Ebina T
    Clin Cancer Res; 1997 Apr; 3(4):633-43. PubMed ID: 9815731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Increased amounts of IL-10 mRNA in anaplastic astrocytomas and glioblastoma multiforme].
    Huettner C; Paulus W; Roggendorf W
    Verh Dtsch Ges Pathol; 1994; 78():418-22. PubMed ID: 7534012
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Vaccination elicits correlated immune and clinical responses in glioblastoma multiforme patients.
    Wheeler CJ; Black KL; Liu G; Mazer M; Zhang XX; Pepkowitz S; Goldfinger D; Ng H; Irvin D; Yu JS
    Cancer Res; 2008 Jul; 68(14):5955-64. PubMed ID: 18632651
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Immunfluorescence of human brain tumours (author's transl)].
    Böker DK
    Acta Neurochir (Wien); 1978; 41(4):363-71. PubMed ID: 356525
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Use of a vaccine strain of measles virus genetically engineered to produce carcinoembryonic antigen as a novel therapeutic agent against glioblastoma multiforme.
    Phuong LK; Allen C; Peng KW; Giannini C; Greiner S; TenEyck CJ; Mishra PK; Macura SI; Russell SJ; Galanis EC
    Cancer Res; 2003 May; 63(10):2462-9. PubMed ID: 12750267
    [TBL] [Abstract][Full Text] [Related]  

  • 31. PHF3-specific antibody responses in over 60% of patients with glioblastoma multiforme.
    Struss AK; Romeike BF; Munnia A; Nastainczyk W; Steudel WI; König J; Ohgaki H; Feiden W; Fischer U; Meese E
    Oncogene; 2001 Jul; 20(31):4107-14. PubMed ID: 11464277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Costal micrometastasis from a cerebral astrocytoma. Immunohistochemical detection (author's transl)].
    Pasquier B; Lachard A; Pasquier D; Muller F; Couderc P; Courel-Vidard MN; Girard N; Delpech B
    Arch Anat Cytol Pathol; 1982; 30(1):50-5. PubMed ID: 6282226
    [No Abstract]   [Full Text] [Related]  

  • 33. MAGE-E1, a new member of the melanoma-associated antigen gene family and its expression in human glioma.
    Sasaki M; Nakahira K; Kawano Y; Katakura H; Yoshimine T; Shimizu K; Kim SU; Ikenaka K
    Cancer Res; 2001 Jun; 61(12):4809-14. PubMed ID: 11406556
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Activated lymphocytes in glioblastoma: significance for anti-tumoral immunity.
    Lorusso L; Nano R; Capelli E; Marinu-Aktipi K; Benericetti E; Giardini G; Ceroni M
    Acta Neurol (Napoli); 1994 Aug; 16(4):198-205. PubMed ID: 7856474
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Antigen-specific immunotherapy as a component of combined therapy for malignant brain tumors].
    Ostanin AA; Tsentner MI; Khonina NA; Leplina OIu; Shevela EIa; Nikonov SD; Stupak VV; Chërnykh ER
    Vopr Onkol; 2003; 49(2):170-5. PubMed ID: 12785199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Vaccine for aggressive brain tumors may prolong survival.
    Health News; 2004 Dec; 10(12):7. PubMed ID: 15645564
    [No Abstract]   [Full Text] [Related]  

  • 37. [Autoimmune hemolytic anemias (author's transl)].
    Wybran J; Lambermont M
    Rev Med Brux; 1981 Mar; 2(3):315-27. PubMed ID: 7015446
    [No Abstract]   [Full Text] [Related]  

  • 38. Glioblastoma-derived mechanisms of systemic immunosuppression.
    Waziri A
    Neurosurg Clin N Am; 2010 Jan; 21(1):31-42. PubMed ID: 19944964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Soluble class HLA antigens in serum of patients with brain tumors].
    Turowski G; Gościński I; Gieracka D; Kedzierska A; Pawłowska E; Danilewicz B
    Pol Merkur Lekarski; 1996 Dec; 1(6):410-1. PubMed ID: 9273234
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Autoimmune response in the serum of patients with cerebral gliomas].
    González C; Fumanal FJ; Roda JE
    Rev Clin Esp; 1984 Apr; 173(1):45-7. PubMed ID: 6739896
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.